Clinical Drug Experience Knowledgebase

soybean (1 trial)

atezolizumab (Tecentriq) (3 trials)

bevacizumab (avastin) (1 trial)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (3 trials)

citric acid (1 trial)

doxorubicin (Doxil) (2 trials)

gemcitabine (gemzar) (5 trials)

magnesium oxide (1 trial)

niraparib (zejula) (2 trials)

paclitaxel (taxol) (5 trials)

polyethylene glycol (1 trial)

sodium picosulfate (Preopik) (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

agen1884 (1 trial)

alocelyvir (1 trial)

binimetinib (mektovi) (1 trial)

cabozantinib (cometriq) (3 trials)

capecitabine (xeloda) (2 trials)

cetuximab (erbitux) (1 trial)

dasatinib (sprycel) (1 trial)

docetaxel (taxotere) (1 trial)

dostarlimab (Jemperli) (1 trial)

doxycycline (vibramycin) (1 trial)

durvalumab (imfinzi) (2 trials)

erlotinib (tarceva) (2 trials)

etoposide (vepesid) (1 trial)

Filgrastim (neupogen) (1 trial)

fluorouracil (efudex) (1 trial)

irinotecan (Camptosar) (2 trials)

methotrexate (1 trial)

mitomycin (mutamycin) (1 trial)

nivolumab (opdivo) (1 trial)

nlm-001 (1 trial)

olaparib (lynparza) (2 trials)

oxaliplatin (eloxatin) (1 trial)

palbociclib (ibrance) (2 trials)

pemetrexed (alimta) (1 trial)

plitidepsin (2 trials)

ponatinib (iclusig) (1 trial)

Raltitrexed (1 trial)

regorafenib (stivarga) (1 trial)

ruxolitinib (jakafi) (1 trial)

simvastatin (zocor) (1 trial)

sorafenib (nexavar) (1 trial)

topotecan (hycamtin) (1 trial)

tremelimumab (Imjudo) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

vinblastine (velban) (1 trial)

vinorelbine (navelbine) (1 trial)

bacille calmette-guerin (1 trial)

fulvestrant (faslodex) (1 trial)

opb-111077 (1 trial)

rogaratinib (1 trial)